True Wealth Design, LLC Supernus Pharmaceuticals, Inc. Transaction History
True Wealth Design, LLC
- $263 Billion
- Q1 2025
A detailed history of True Wealth Design, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 106 shares of SUPN stock, worth $3,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106
Previous 105
0.95%
Holding current value
$3,416
Previous $3.8 Million
8.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$335 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$199 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$167 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$93.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$87 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.72B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...